PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Klotz, L.V. ; Courty, Y.* ; Lindner, M. ; Petit-Courty, A.* ; Stowasser, A.* ; Koch, I.* ; Eichhorn, M.E.* ; Lilis, I.* ; Morresi-Hauf, A.* ; Arendt, K.A.M. ; Pepe, M. ; Giopanou, I.* ; Ntaliarda, G.* ; Behrend, S.J. ; Oplopoiou, M.* ; Gissot, V.* ; Guyetant, S.* ; Marchand-Adam, S.* ; Behr, J. ; Kaiser, J.C. ; Hatz, R.A. ; Lamort, A.-S. ; Stathopoulos, G.T.

Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors.

Cancer Med. 8, 1486-1499 (2019)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
A comprehensive characterization of lung adenocarcinoma (LADC) clinical features is currently missing. We prospectively evaluated Caucasian patients with early-stage LADC. Patients with LADC diagnosed between 2011 and 2015 were prospectively assessed for lung resection with curative intent. Fifty clinical, pathologic, radiologic, and molecular variables were recorded. Patients were followed till death/study conclusion. The main findings were compared to a separate cohort from France. Of 1943 patients evaluated, 366 were enrolled (18.8%; 181 female; 75 never-smokers; 28% of registered Bavarian cases over the study period). Smoking and obstruction were significantly more prevalent in GLAD compared with adult Bavarians (P<0.0001). Ever-smoker tumors were preferentially localized to the upper lobes. We observed 120 relapses and 74 deaths over 704 cumulative follow-up years. Median overall and disease-free survival were >7.5 and 3.6years, respectively. Patients aged <45 or >65years, resected >60days postdiagnosis, with abnormal FVC/DLCOVA, N2/N3 stage, or solid histology had significantly decreased survival estimates. These were fit into a weighted locoregional LADC death risk score that outperformed pTNM7 in predicting survival in the GLAD and in our second cohort. We define the clinical gestalt of locoregional LADC and provide a new clinical tool to predict survival, findings that may aid future management and research design.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.357
1.081
2
5
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Ladc ; Lung Adenocarcinoma ; Obstruction ; Smoking ; Survival; International Association; Cancer; Classification; Mortality
Language english
Publication Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 2045-7634
e-ISSN 2045-7634
Journal Cancer Medicine
Quellenangaben Volume: 8, Issue: 4, Pages: 1486-1499 Article Number: , Supplement: ,
Publisher Wiley
Publishing Place Hoboken, NJ
Reviewing status Peer reviewed
Institute(s) Institute of Lung Health and Immunity (LHI)
Institute of Radiation Medicine (IRM)
POF-Topic(s) 30202 - Environmental Health
30203 - Molecular Targets and Therapies
Research field(s) Lung Research
Radiation Sciences
PSP Element(s) G-501600-003
G-501600-011
G-501391-001
DOI 10.1002/cam4.2031
WOS ID WOS:000477027100016
Scopus ID 85062352606
PubMed ID 30806043
Erfassungsdatum 2019-03-19
[➜Report correction]